Sinphar Pharmaceutical Co. Ltd. (1734.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.01B |
| Enterprise Value | 5.65B |
| P/E Ratio | 16.51 |
| PEG Ratio | 1.88 |
| Price/Sales Ratio | 1.79 |
| Price/Book Ratio | 1.67 |
| Enterprise/Revenue | 1.96 |
| Enterprise/EBITDA | 9.83 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 3.37B |
| Revenue/Share | 18.38 |
| Gross Profit | 1.46B |
| EBITDA | 689.7M |
| Net Income | 365.75M |
| Diluted EPS | 1.92 |
Balance Sheet
| Total Cash | 1.6B |
| Total Cash/Share | 8.5 |
| Total Debt | 2.05B |
| Total Debt/Equity | 0.59 |
| Current Ratio | 2.04 |
| Book Value Per Share | 19.82 |
Price History
| 52-Week Change | 10.39 |
| 52-Week High | 32.8 |
| 52-Week Low | 26.52 |
| Moving Average 50 Days | 31.24 |
| Moving Average 200 Days | 28.89 |
Statistics
| Average Volume | 238,718 |
| Shares Outstanding | 201.61M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.94 |
| Trailing Annual Dividend Yield | 3.07 |
| Payout Ratio | 0.52 |
| Last Split Factor | 53:50 |
| Last Split Date | August 27, 2026 |
AD
